全文获取类型
收费全文 | 7652篇 |
免费 | 382篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 135篇 |
儿科学 | 159篇 |
妇产科学 | 109篇 |
基础医学 | 1052篇 |
口腔科学 | 207篇 |
临床医学 | 443篇 |
内科学 | 1801篇 |
皮肤病学 | 133篇 |
神经病学 | 504篇 |
特种医学 | 250篇 |
外科学 | 1314篇 |
综合类 | 35篇 |
预防医学 | 234篇 |
眼科学 | 180篇 |
药学 | 459篇 |
中国医学 | 15篇 |
肿瘤学 | 1061篇 |
出版年
2023年 | 58篇 |
2022年 | 114篇 |
2021年 | 190篇 |
2020年 | 99篇 |
2019年 | 144篇 |
2018年 | 140篇 |
2017年 | 142篇 |
2016年 | 143篇 |
2015年 | 171篇 |
2014年 | 207篇 |
2013年 | 252篇 |
2012年 | 385篇 |
2011年 | 375篇 |
2010年 | 224篇 |
2009年 | 192篇 |
2008年 | 316篇 |
2007年 | 395篇 |
2006年 | 370篇 |
2005年 | 374篇 |
2004年 | 299篇 |
2003年 | 298篇 |
2002年 | 270篇 |
2001年 | 249篇 |
2000年 | 224篇 |
1999年 | 209篇 |
1998年 | 101篇 |
1997年 | 85篇 |
1996年 | 82篇 |
1995年 | 58篇 |
1994年 | 53篇 |
1993年 | 68篇 |
1992年 | 174篇 |
1991年 | 166篇 |
1990年 | 155篇 |
1989年 | 160篇 |
1988年 | 121篇 |
1987年 | 138篇 |
1986年 | 97篇 |
1985年 | 90篇 |
1984年 | 77篇 |
1983年 | 77篇 |
1982年 | 37篇 |
1981年 | 38篇 |
1980年 | 32篇 |
1979年 | 62篇 |
1978年 | 47篇 |
1977年 | 40篇 |
1975年 | 31篇 |
1973年 | 28篇 |
1970年 | 33篇 |
排序方式: 共有8091条查询结果,搜索用时 15 毫秒
71.
72.
Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. 总被引:5,自引:0,他引:5
73.
Surgical series of hearing preservation in acoustic neuroma usually emphasize a team's results with one particular technique. This report reviews acoustic neuroma outcomes of individualizing the surgical approach to patient and tumor characteristics. This study reviews 60 consecutive hearing preservation acoustic neuroma surgeries in a total series of 330 acoustic neuromas. Tumor sizes ranged from 0.3 to 4 cm in patients ranging from 23 to 74 years of age. Middle fossa surgery was performed in 57%, retrosigmoid in 43%. Overall, measurable hearing was preserved in 77%, and useful hearing in 67%. Among middle fossa cases, 85% had measurable and 74% had useful hearing. Among retrosigmoid surgeries, 65% had measurable hearing and 58% had useful hearing. Overall, long-term facial nerve function was excellent (grade I or II) in 90% and poor (grade V or VI) in 2%. There was one case of bacterial meningitis(2%), and cerebrospinal fluid leaks requiring surgery occurred in four patients (7%). The hearing preservation and other outcome parameters in this series compare favorably with other reports. We believe that individualizing the surgical approach to the patient's tumor characteristics and clinical features contributed to the high rate of hearing preservation. 相似文献
74.
75.
Usefulness of three-dimensional CT cholangiography for patients prior to laparoscopic cholecystectomy 总被引:2,自引:0,他引:2
Toyoda H Hayakawa K Kikkawa M Fukushima H Kataoka M Mukaihara S Nishimura K Kawakami S 《Radiation Medicine》2000,18(3):161-166
PURPOSE: The aim of this study was to demonstrate three-dimensional biliary anatomy by using spiral CT scanning for patients prior to laparoscopic cholecystectomy. MATERIALS AND METHODS: We studied 22 patients (11 men, 11 women; mean age, 60 years) with preoperative imaging. All patients had normal serum bilirubin levels. Either 50 ml (in 10 cases) or 100 ml (in 12 cases) of meglumine iotroxate was infused intravenously over 30 minutes. Spiral CT scanning was started immediately after the infusion was finished. Volumetric data through the entire biliary tracts were obtained during one breath-hold. The data were reconstructed by using a maximum intensity projection algorithm and three-dimensional shaded surface rendering. RESULTS: In all patients, the anatomical relationship between the cystic duct and the common bile duct was clearly depicted, including one with junctional anomaly. The intrahepatic biliary ducts and the confluence of the hepatic ducts were displayed from all angles. The third or higher intrahepatic branches were delineated in 11 of the 12 (92%) patients with the use of 100 ml of the cholangiographic agent and in seven of the 10 (70%) with 50 ml. CONCLUSION: Three-dimensional CT cholangiography was able to provide adequate information about precise biliary anatomy. 相似文献
76.
Shin Kariya Mitsuhiro Okano Hisashi Hattori Yuji Sugata Rie Matsumoto Kunihiro Fukushima Patricia A Schachern Sebahattin Cureoglu Michael M Paparella Kazunori Nishizaki 《Otology & neurotology》2006,27(8):1089-1093
OBJECTIVE: Otitis media with effusion is one of the most common and intractable ear diseases. However, the role of Th1, Th2, and immunoregulatory cytokines on the pathogenesis of the disease in adult patients remains to be determined. The aim of this study is to disclose the cytokine expression in middle ear effusions (MEEs) in adults and to compare the profile on the basis of the presence of allergic rhinitis and the type of effusions. STUDY DESIGN: A prospective controlled clinical study. PATIENTS: MEEs were collected from 80 adult subjects. The concentration of interleukin (IL)-2, IL-4, IL-5, IL-10, IL-12, and interferon (IFN)-gamma in MEEs were determined by using enzyme-linked immunosorbent assay. RESULTS: IL-2, IL-4, IL-5, IL-10, IL-12, and IFN-gamma in MEEs were detected in 60 (75.0%), 33 (41.3%), 42 (52.5%), 14 (17.5%), 80 (100%), and 66 (82.5%) samples, respectively. Among these cytokines, only the concentration of IL-4 in the allergic rhinitis-positive group was significantly higher than that in the allergic rhinitis-negative group. On the other hand, IL-2, IL-12, and IFN-gamma were detected, regardless of the presence of allergic rhinitis, and the concentration of these cytokines correlated with each other. The correlation between the concentration of IL-4 and IL-5 was also detected. In addition, both the incidence rate and the concentration of IL-10 in MEEs were significantly higher in the mucoid type compared with those in the serous type effusions. CONCLUSION: Regardless of allergic status, IL-12 may play a critical role in the pathogenesis of otitis media with effusion by affecting the production of IL-2 and IFN-gamma. In addition, IL-4 may have some impact on the immunologic condition in adults with allergic rhinitis. IL-10 potentially affects the viscosity of MEEs. 相似文献
77.
Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. 总被引:5,自引:0,他引:5
T Fukushima Y Miyazaki S Honda F Kawano Y Moriuchi M Masuda R Tanosaki A Utsunomiya N Uike S Yoshida J Okamura M Tomonaga 《Leukemia》2005,19(5):829-834
Adult T-cell leukemia/lymphoma (ATLL) is a distinct peripheral T-cell neoplasm that is highly resistant to chemotherapy. Several groups, including ours, have reported encouraging results of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with ATLL. To confirm our previous report and to establish the basis for a phase II clinical study, we analyzed 40 allo-HSCT for acute and lymphoma types of ATLL in seven institutions in Japan between 1997 and 2002. All evaluable cases entered complete remission (CR) after allo-HSCT and the median survival time was 9.6 months for all patients. The estimated 3-year overall and relapse-free survival, and disease relapse were 45.3, 33.8 and 39.3%, respectively. Among 10 cases with ATLL relapse, five cases achieved CR again: three by the reduction or cessation of immunosuppressive agents, which suggested a graft-versus-ATLL (GvATLL) effect. However, univariate or multivariate analysis did not show any benefit of graft-versus-host disease (GVHD) on the prevention of relapse. These results suggested that allo-HSCT was effective for some patients with aggressive ATLL, and that the GvATLL effect could be achieved even without GVHD. A new phase II trial to test the efficacy of allo-HSCT for ATLL is warranted. 相似文献
78.
79.
Yoshiaki Ikuta Tetsuya Nakatsura Toshiro Kageshita Satoshi Fukushima Shosuke Ito Kazumasa Wakamatsu Hideo Baba Yasuharu Nishimura 《Clinical cancer research》2005,11(22):8079-8088
PURPOSE: There are no available tumor markers detecting primary melanoma at an early stage. The identification of such serum markers would be of significant benefit for an early diagnosis of melanoma. We recently identified glypican-3 (GPC3) as a novel tumor marker but could diagnose only 40% of melanomas. Thereby, we focused out attention on secreted protein acidic and rich in cysteine (SPARC) overexpressed in melanoma as another candidate for tumor marker. EXPERIMENTAL DESIGN: Secreted SPARC protein was quantified using ELISA in the sera from 109 melanoma patients, five patients with large congenital melanocytic nevus, 61 age-matched healthy donors, and 13 disease-free patients after undergoing a surgical removal. We also quantified GPC3 and 5-S-cysteinyldopa in the same serum samples and compared these markers for their diagnostic value. RESULTS: The serum SPARC concentrations in melanoma patients were greater than those in healthy donors (P = 0.001). When we fixed a cutoff value at the mean concentration plus 2 SD of the healthy donors, the serum SPARC was found to have increased in the sera of 36 of the 109 (33%) melanoma patients, whereas there were three (4.9%) false-positive cases of 61 healthy donors. Surprisingly, 19 of 36 patients showing increased SPARC levels were in stages 0 to II. The serum SPARC level decreased under the cutoff level in 10 of 13 patients after surgical removal. Using SPARC and GPC3 in combination thus enabled us to diagnose 47 of 75 (66.2%) melanoma patients at an early stage (0-II). CONCLUSIONS: SPARC or its combination with GPC3 is thus considered a potentially useful tumor marker, especially for melanoma at an early stage. 相似文献
80.
Robert T. Dorr MD Mary Ann Raymond Terry H. Landowski Nicholas O. Roman Shoji Fukushima 《Journal of gastrointestinal cancer》2005,36(1):15-28
Imexon is an aziridine-containing small molecule currently in Phase I clinical trials. This agent has been shown to bind to thiols and increase intracellular oxidants, inducing apoptosis in hematologic cancer cells. Pancreatic cancers are known to be sensitive to oxidation, suggesting this disease may be an appropriate target for this agent. The current report examines the activity of imexon in pancreatic cells. Imexon induced concentration-dependent and time-dependent apoptosis in a panel of six human pancreatic carcinoma cell (PCC) lines. The mean IC50 (SD) for growth inhibition by the SRB assay was 200 (101) µM for a 48 h exposure with a range of 64–358 µM. Cell killing was schedule-dependent, favoring exposure times ≥48 h. Imexon-treated MiaPaCa-2 cells underwent non-lethal growth arrest following exposure to concentrations ≤200 µM for 48 h. When concentrations were increased to 300 µM for ≥48 h, the MiaPaCa-2 cells arrested in G2 phase and activated caspases 3, 8, and 9 were detected. After a 72 h exposure to the IC80 concentration of imexon, cells exhibited a loss of mitochondrial membrane potential detected by CMXRos staining. However, there was no loss of reduced cellular thiols unless very high concentrations of ≥400 µM were used. In contrast, reactive oxygen species (ROS) were elevated in a dose-dependent fashion, starting at very low imexon concentrations. Imexon also significantly inhibited MiaPaCa-2 tumor growth in SCID mice at 100 mg/kg/d for 9 d. The tumor growth inhibition (% T/C) was 27% of control, and the tumor growth delay was 21 d, indicating an active agent by NCI standards. The levels of imexon that are cytotoxic in human PCC’s are achievable based on the preliminary results of the ongoing Phase I trial. Imexon appears to be active against PCCs in vitro and has an entirely novel mechanism of action involving G2 arrest, accumulation of ROS, and the induction of apoptosis. 相似文献